Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial

Why did oil prices surge after Israel’s strike on Iran? How will Israel-Iran conflict impact global markets? What caused the sharp drop in European shares today? Why is Bitcoin falling after Middle East tensions escalate? How will Meta’s investment affect Scale AI’s growth? What’s behind Tesla’s lawsuit against former engineer? How is the Air India crash affecting Boeing’s stock?

Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial

ir.novavax.com/press-releases/2025-06-11-Novavaxs-COVID-19-Influenza-Combination-and-Stand-alone-Influenza-Vaccine-Candidates-Showed-Robust-Immune-Responses-and-Were-Well-Tolerated-in-Initial-Cohort-of-a-Phase-3-Trial

Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial
- Both vaccine candidates induced robust immune responses across all antigens tested
- No new safety signals…

This story appeared on ir.novavax.com, 2025-06-12 06:54:27.516000.